Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96RR1: Variant p.Ala359Thr

Twinkle mtDNA helicase
Gene: TWNK
Feedback?
Variant information Variant position: help 359 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Alanine (A) to Threonine (T) at position 359 (A359T, p.Ala359Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PEOA3; reduces helicase activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 359 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 684 The length of the canonical sequence.
Location on the sequence: help QPRPLEALNGGFNLSRILRT A LPAWHKSIVSFRQLREEVLG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         QPRPLEALNGGFNLSRILRTALPAWHKSIVSFRQLREEVLG

Mouse                         QPRPLEALNQGLSLPRILRTALPAWHKSIVSFRQLREEVLG

Chicken                       QPRPLEALNRGLNLTKILRAALPAGHKAIVSFRQLREEVFG

Drosophila                    EPAPHLALRRRLNLRHILAKATPVQHKAITTFGAMRNDILS
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 32 – 684 Twinkle mtDNA helicase
Region 121 – 372 Required for hexamers formation and DNA helicase activity



Literature citations
Human mitochondrial DNA deletions associated with mutations in the gene for Twinkle, a phage T7 gene 4-like protein localized in mitochondria.
Spelbrink J.N.; Li F.-Y.; Tiranti V.; Nikali K.; Yuan Q.-P.; Tariq M.; Wanrooij S.; Garrido N.; Comi G.; Morandi L.; Santoro L.; Toscano A.; Fabrizi G.-M.; Somer H.; Croxen R.; Beeson D.; Poulton J.; Suomalainen A.; Jacobs H.T.; Zeviani M.; Larsson C.;
Nat. Genet. 28:223-231(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2); TISSUE SPECIFICITY; SUBCELLULAR LOCATION; VARIANT ILE-368; VARIANTS PEOA3 LEU-315; PRO-354; THR-359; THR-367; PRO-369; GLN-374; PRO-381; CYS-474 AND PRO-475; Twinkle mutations associated with autosomal dominant progressive external ophthalmoplegia lead to impaired helicase function and in vivo mtDNA replication stalling.
Goffart S.; Cooper H.M.; Tyynismaa H.; Wanrooij S.; Suomalainen A.; Spelbrink J.N.;
Hum. Mol. Genet. 18:328-340(2009)
Cited for: FUNCTION (ISOFORM 1); CATALYTIC ACTIVITY (ISOFORM 1); SUBUNIT (ISOFORM 1); SUBCELLULAR LOCATION; CHARACTERIZATION OF VARIANTS LEU-315; GLU-319; THR-359; PRO-369; GLN-374 AND CYS-474; The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO.
Fratter C.; Gorman G.S.; Stewart J.D.; Buddles M.; Smith C.; Evans J.; Seller A.; Poulton J.; Roberts M.; Hanna M.G.; Rahman S.; Omer S.E.; Klopstock T.; Schoser B.; Kornblum C.; Czermin B.; Lecky B.; Blakely E.L.; Craig K.; Chinnery P.F.; Turnbull D.M.; Horvath R.; Taylor R.W.;
Neurology 74:1619-1626(2010)
Cited for: VARIANTS PEOA3 GLN-303; TRP-303; GLN-334; PRO-354; PRO-357; THR-359; PRO-362; LEU-363; CYS-370; GLN-374; PRO-381; HIS-458; PRO-460; ASP-475 AND LYS-479;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.